HIV
From the Journals
CAR T-cell therapy found safe, effective for HIV-associated lymphoma
Two HIV-positive patients with chemotherapy-refractory, high-grade B-cell lymphoma achieved complete remission with anti-CD19 CAR T-cell therapy,...
From the Journals
New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial
From the Journals
Stem cells gene edited to be HIV resistant treat ALL, but not HIV
Opinion
Summary: Preexposure prophylaxis for the prevention of HIV infection USPSTF recommendation statement
New cases of HIV might be decreasing overall, but the incidence is rising in some groups.
From the Journals
HCV coinfection adds to cardiovascular risk in HIV-infected patients
News
FDA panel backs Descovy as HIV PrEP for men and transgender women who have sex with men
Conference Coverage
Novel translocation inhibitor shows efficacy in treatment-naive HIV-1–infected adults
Potent, first-in-class antiretroviral drug may eventually allow for once-weekly or once-monthly dosing, investigator says.
Conference Coverage
Antiretroviral-eluting implant could provide HIV prophylaxis for a year or more
The long-term islatravir implant could one day provide an easier adherence alternative for many.
Conference Coverage
Two-drug integrase inhibitor–based regimen noninferior to standard in HIV-infected adults
In light of these findings and those from other studies, it may be time to “rethink the position of dual therapy in the international guidelines...
Conference Coverage
New WHO recommendations promote dolutegravir benefits in the face of lowered risk signal for neural tube defects
News
More than half of U.S. adults have never received HIV screening